USPTO serial 90271856
MEPSEVII
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 13, 2021
- Examiner
- VENGROFF, MARILYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MEPSEVII?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $325
Owner
Ultragenyx Pharmaceutical Inc.
Novato, CA, US
Ultragenyx Pharmaceutical Inc.
Novato, CA, US
Ultragenyx Pharmaceutical Inc.
Novato, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian Focarino
Brian Focarino Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700ATTN: IP Docketing DepartmentWashington, DC 20004-2400Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders and enzyme disorders | ACTIVE | Dec 20, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ultragenyx Pharmaceutical Inc.
- Other trademarks owned by Ultragenyx Pharmaceutical Inc.
- Other trademarks owned by Ultragenyx Pharmaceutical Inc.
- Other trademarks in Class 005
- Similar marks named MEPSEVII
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 2, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 2, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 2, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 2, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 13, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 27, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 27, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 7, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 23, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2020 | NWAP | NEW APPLICATION ENTERED | — |